Genomics of Cardiovascular Disease

As the leading cause of death worldwide and a major cause of disability, cardiovascular disease remains a central focus of basic pharmacological treatment, Surgical interventions, and long-term care. Inherited, monogenic syndromes have provided insight into pathophysiological mechanisms across die range of cardiovascular diseases. with the advent Of post-Human Genome Project resources and technology, there has been a flood of research aimed at genome-wide predisposition markers pharmacogenetics, and genomic signatures in c complex Cardiovascular disorders. Genomic research has both further elucidated the impact of genes previous,sly identified in cardiovascular disease development and progression and discovered genomic regions as yet unknown to be associated with cardiovascular outcomes. The promise of personalized medicine lies in combining this genetic information with other biomarkers to tailor preventive and therapeutic strategies to individual patients for effective management, fewer adverse events, and preventive care. Mt Sinai J Med 76:613-623, 2009. (C) 2009 Mount Sinai School of Medicine